FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315710014> ?p ?o ?g. }

• W4315710014 endingPage "434" @default.
• W4315710014 startingPage "428" @default.
• W4315710014 abstract "Abstract Background: Preclinical evidence suggests that 5α-reductase inhibitors (5ARi), commonly used to treat benign prostatic hyperplasia (BPH), are associated with reduced incidence of certain urologic cancers, yet epidemiologic studies are conflicting. This study aimed to determine whether 5ARi's are associated with a reduced risk of kidney and bladder cancers. Methods: We conducted a new-user active-comparator cohort study in the United Kingdom Clinical Practice Research Datalink. From a base cohort of patients with incident BPH, new users of 5ARi's and α-blockers were identified. Patients were followed up until a first ever diagnosis of kidney or bladder cancer, death from any cause, end of registration, or December 31, 2017. Cox proportional hazards models were used to calculate HRs and 95% confidence intervals (CI) for incident kidney and bladder cancer. Results: There were 5,414 and 37,681 new users of 5ARi's and α-blockers, respectively. During a mean follow-up of 6.3 years, we found no association between the use of 5ARi's and kidney (adjusted HR, 1.26; 95% CI, 0.74–2.12; n = 23) or bladder (adjusted HR, 0.89; 95% CI, 0.64–1.23; n = 57) cancer risk compared with α-blockers. Similar results were observed across sensitivity analyses. Conclusions: In this study, we found no association between the use of 5ARi's and kidney or bladder cancer incidence in men with BPH when compared with α-blocker use. Impact: The findings of this study indicate that 5ARi's are unlikely to reduce kidney or bladder cancer risk." @default.
• W4315710014 created "2023-01-12" @default.
• W4315710014 creator A5006088032 @default.
• W4315710014 creator A5009413112 @default.
• W4315710014 creator A5028735116 @default.
• W4315710014 creator A5044126197 @default.
• W4315710014 creator A5050015458 @default.
• W4315710014 creator A5071893340 @default.
• W4315710014 date "2023-01-12" @default.
• W4315710014 modified "2023-10-17" @default.
• W4315710014 title "5α-Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study" @default.
• W4315710014 cites W1216083017 @default.
• W4315710014 cites W1491207647 @default.
• W4315710014 cites W1849521086 @default.
• W4315710014 cites W1985359478 @default.
• W4315710014 cites W2020105514 @default.
• W4315710014 cites W2038981426 @default.
• W4315710014 cites W2065974896 @default.
• W4315710014 cites W2079396916 @default.
• W4315710014 cites W2102994534 @default.
• W4315710014 cites W2111714917 @default.
• W4315710014 cites W2119852447 @default.
• W4315710014 cites W2134555283 @default.
• W4315710014 cites W2598033410 @default.
• W4315710014 cites W2757713854 @default.
• W4315710014 cites W2794961895 @default.
• W4315710014 cites W2801385988 @default.
• W4315710014 cites W2889646458 @default.
• W4315710014 cites W2895926103 @default.
• W4315710014 cites W2974789253 @default.
• W4315710014 cites W2982188023 @default.
• W4315710014 cites W2989939172 @default.
• W4315710014 cites W2995525013 @default.
• W4315710014 cites W3023476794 @default.
• W4315710014 cites W3025205563 @default.
• W4315710014 cites W3080106427 @default.
• W4315710014 cites W3084094503 @default.
• W4315710014 cites W3086744642 @default.
• W4315710014 cites W3131159528 @default.
• W4315710014 cites W4206917617 @default.
• W4315710014 doi "https://doi.org/10.1158/1055-9965.epi-22-1109" @default.
• W4315710014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36634196" @default.
• W4315710014 hasPublicationYear "2023" @default.
• W4315710014 type Work @default.
• W4315710014 citedByCount "0" @default.
• W4315710014 crossrefType "journal-article" @default.
• W4315710014 hasAuthorship W4315710014A5006088032 @default.
• W4315710014 hasAuthorship W4315710014A5009413112 @default.
• W4315710014 hasAuthorship W4315710014A5028735116 @default.
• W4315710014 hasAuthorship W4315710014A5044126197 @default.
• W4315710014 hasAuthorship W4315710014A5050015458 @default.
• W4315710014 hasAuthorship W4315710014A5071893340 @default.
• W4315710014 hasBestOaLocation W43157100142 @default.
• W4315710014 hasConcept C120665830 @default.
• W4315710014 hasConcept C121332964 @default.
• W4315710014 hasConcept C121608353 @default.
• W4315710014 hasConcept C126322002 @default.
• W4315710014 hasConcept C126894567 @default.
• W4315710014 hasConcept C143998085 @default.
• W4315710014 hasConcept C201903717 @default.
• W4315710014 hasConcept C2778527826 @default.
• W4315710014 hasConcept C2780352672 @default.
• W4315710014 hasConcept C2781068499 @default.
• W4315710014 hasConcept C29456083 @default.
• W4315710014 hasConcept C50382708 @default.
• W4315710014 hasConcept C61511704 @default.
• W4315710014 hasConcept C71924100 @default.
• W4315710014 hasConcept C72563966 @default.
• W4315710014 hasConceptScore W4315710014C120665830 @default.
• W4315710014 hasConceptScore W4315710014C121332964 @default.
• W4315710014 hasConceptScore W4315710014C121608353 @default.
• W4315710014 hasConceptScore W4315710014C126322002 @default.
• W4315710014 hasConceptScore W4315710014C126894567 @default.
• W4315710014 hasConceptScore W4315710014C143998085 @default.
• W4315710014 hasConceptScore W4315710014C201903717 @default.
• W4315710014 hasConceptScore W4315710014C2778527826 @default.
• W4315710014 hasConceptScore W4315710014C2780352672 @default.
• W4315710014 hasConceptScore W4315710014C2781068499 @default.
• W4315710014 hasConceptScore W4315710014C29456083 @default.
• W4315710014 hasConceptScore W4315710014C50382708 @default.
• W4315710014 hasConceptScore W4315710014C61511704 @default.
• W4315710014 hasConceptScore W4315710014C71924100 @default.
• W4315710014 hasConceptScore W4315710014C72563966 @default.
• W4315710014 hasFunder F4320319985 @default.
• W4315710014 hasIssue "3" @default.
• W4315710014 hasLocation W43157100141 @default.
• W4315710014 hasLocation W43157100142 @default.
• W4315710014 hasLocation W43157100143 @default.
• W4315710014 hasOpenAccess W4315710014 @default.
• W4315710014 hasPrimaryLocation W43157100141 @default.
• W4315710014 hasRelatedWork W1411054225 @default.
• W4315710014 hasRelatedWork W1969272931 @default.
• W4315710014 hasRelatedWork W1969503742 @default.
• W4315710014 hasRelatedWork W1973565412 @default.
• W4315710014 hasRelatedWork W1992459022 @default.
• W4315710014 hasRelatedWork W2122992204 @default.
• W4315710014 hasRelatedWork W2396935886 @default.
• W4315710014 hasRelatedWork W2596040508 @default.

• next